Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Stroke. 2013 Jan 29;44(3):612–619. doi: 10.1161/STROKEAHA.112.672089

Table 3.

Genetic score analysis

Cases/Controls Full OXPHOS Complex I Complex IV
OR
(95% CI)
p OR
(95% CI)
p OR
(95% CI)
p
All
ischemic
stroke
1048/1384 1.17
(1.03-
1.33)
0.008 1.06
(1.00-1.12)
0.050 1.05
(0.99-1.12)
0.075
 SV only 197/1384 1.16
(1.04-
1.29)
0.007 1.13
(1.01-1.26)
0.027 1.14
(1.02-1.27)
0.018

All ICH 928/548 --- --- --- --- 1.08
(1.01-1.17)
0.039
 Deep
only
430/548 --- --- --- --- 1.14
(1.03-1.25)
0.008

Genetic score analysis results in the ISGS/SWISS validation cohort and ISGC ICH extension cohort, performed only on gene sets and subgroups with significant p-values in gene set enrichment analysis. Odds ratios represent risk per unit increase in risk score quintile.

CI = confidence interval, OR = odds ratio, OXPHOS = all structural proteins directly contributing to oxidative phosphorylation complex function, SV = small vessel stroke, --- = analysis not performed.

Nominal p-values are reported for association with ischemic stroke and ICH in the validation and extension cohorts.